Shenglong Li
- Molecular Biology top 10%
- Cancer Research top 5%
- Biomedical Engineering top 5%
- Oncology top 10%
- Immunology top 10%
- Co-authors
- Xudong ZhuXiaojing ZhangYi PeiKe ZhengWei WangMengdan XuDongguang XiaoAiqun Yu
- Topics
- MicroRNA in disease regulation (17 papers)Extracellular vesicles in disease (14 papers)Circular RNAs in diseases (13 papers)
- Journals
- SHILAP Revista de lepidopterologíaDiabetesJournal of Power Sources
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Shenglong Li
109 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Molecular Biology 1.2k
- Cancer Research 612
- Biomedical Engineering 560
- Oncology 339
- Immunology 262
Countries citing papers authored by Shenglong Li
This map shows the geographic impact of Shenglong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglong Li more than expected).
Fields of papers citing papers by Shenglong Li
This network shows the impact of papers produced by Shenglong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglong Li. The network helps show where Shenglong Li may publish in the future.
Co-authorship network of co-authors of Shenglong Li
This figure shows the co-authorship network connecting the top 25 collaborators of Shenglong Li. A scholar is included among the top collaborators of Shenglong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglong Li. Shenglong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 7 | |
| 6 | 3 | |
| 7 | 8 | |
| 8 | 5 | |
| 9 | 0 | |
| 10 | 9 | |
| 11 | 28 | |
| 12 | 1 | |
| 13 | 8 | |
| 14 | 34 | |
| 15 | 73 | |
| 16 | 3 | |
| 17 | 7 | |
| 18 | 37 | |
| 19 | 1 | |
| 20 | From Transition of Economic System to Transformation of Social System——Historical Positioning of Present Stage Reform and Political Economic Analysis of the Orientation of Harmony | 0 |
About Shenglong Li
Shenglong Li is a scholar working on Cancer Research, Biomaterials and Health Informatics, having authored 121 papers that have together received 2.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), Extracellular vesicles in disease (14 papers) and Circular RNAs in diseases (13 papers). The work is most often cited by research in Cancer Research (612 citations), Molecular Biology (1.2k citations) and Biomaterials (203 citations). Shenglong Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Xudong Zhu, Xiaojing Zhang, Yi Pei, Ke Zheng, Wei Wang, Mengdan Xu, Dongguang Xiao, Aiqun Yu, Cuiying Zhang and Yu Zhao. Their work appears in journals such as SHILAP Revista de lepidopterología, Diabetes and Journal of Power Sources.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.